Frontotemporal lobar degeneration (FTLD) is a collective term for a group of neurodegenerative disorders with predominant atrophy of the frontal and/or the temporal lobes of the brain. Despite similar gross pathologic features, FTLD is markedly heterogeneous in clinical presentation, microscopic characteristics, and underlying genetic causes. Clinically, FTLD presents with either changes in personality and social conduct (behavioral variant frontotemporal dementia [bvFTD]) or with language problems (primary progressive aphasias including semantic dementia [SD] and progressive nonfluent aphasia [PNFA]).
1-3 The pathology of FTLD can, in turn, be subdivided according to the identity of the major inclusion protein that is found in protein depositions in degenerating neurons, those being TAR DNA-binding protein 43 (TDP-43; pathologic subclass, FTLD-TDP), tau (FTLD-tau), and FUS (FTLD-FUS).
4